LianBio Revenue and Competitors

Shanghai,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • LianBio's estimated annual revenue is currently $20.5M per year.(i)
  • LianBio's estimated revenue per employee is $155,000

Employee Data

  • LianBio has 132 Employees.(i)
  • LianBio grew their employee count by 7% last year.

LianBio's People

NameTitleEmail/Phone
1
CEO and DirectorReveal Email/Phone
2
CEOReveal Email/Phone
3
Chief Scientific AdvisorReveal Email/Phone
4
VP, LegalReveal Email/Phone
5
VP, Communications and Investor RelationsReveal Email/Phone
6
VP, Clinical Operations and Translational DevelopmentReveal Email/Phone
7
VP, Head Alliance ManagementReveal Email/Phone
8
Director, Alliance ManagementReveal Email/Phone
9
Managing Director, Head Cross-Border Healthcare Investment BankingReveal Email/Phone
10
Director, U.S. ControllerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is LianBio?

LianBio's mission is to catalyze the development and accelerate availability of paradigm-shifting medicines to patients in China and major Asian markets through partnerships that provide access to the best science-driven therapeutic discoveries. LianBio collaborates with world-class partners across a diverse array of therapeutic and geographic areas to build out a pipeline based on disease relevance and the ability to impact patients with transformative mechanisms and precision-based therapeutics.

keywords:N/A

N/A

Total Funding

132

Number of Employees

$20.5M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

LianBio News

2022-04-06 - LianBio Announces Formation of Scientific Advisory Board

SHANGHAI, China and PRINCETON, N.J., April 14, 2022 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to...

2022-03-30 - LianBio Appoints Wei Wei Chen to Board of Directors

SHANGHAI and PRINCETON, N.J., April 07, 2022 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing...

2022-03-22 - LianBio Reports Fourth Quarter and Full Year 2021 Financial ...

LianBio is a cross-border biotechnology company on a mission to bring transformative medicines to historically underserved patients in China and...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$30.8M135-6%N/A
#2
$33.3M136-18%N/A
#3
$8.9M137-6%N/A
#4
N/A1438%N/A
#5
$23.4M147N/AN/A